Shunxiang Xu

Dr. Shunxiang Xu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Advanced Functional Materials
Verified
Journal Article
Open access
SXShunxiang Xu
Shunxiang Xu
YZYuantao Zhang
Yuantao Zhang
BDBingyang Dai
Bingyang Dai
JRJiancun Rao
Jiancun Rao
FDFanyan Deng
Fanyan Deng
SXShunxiang Xu
Shunxiang Xu
Bioceramics provide promising tactics for wound healing, yet the on‐shelf products are still unmet, especially for skin appendages regeneration. Herein, the inorganic magnesium silicate sprays (MSS) as mineral factors to overcome the existing challenges is proposed. Results indicate MSS can be synthesized by a green method without organic solvents, templates, calcination, and harmful by‐products. With amorphous phase, nanoscale, and high specific surface area, MSS reveal an improved pH‐responsive degradability and excellent bioactivity for cell proliferation and migration. In rats, MSS display a dose‐dependent effect on accelerating burn‐wound repair via regulating the expressions of iNOS and IL‐10 to attenuate inflammation, elevating the expressions of CD31 and α‐SMA to improve vascularization, and boosting collagen deposition without ectopic calcification. The released Mg and Si ions synergistically potentiate the expressions of Gap43, Tubb3, and K19, suggesting the regeneration of peripheral nerves and hair follicles. These superior features are further verified by comparisons with commercial products, Dermlin® and 45S5 bioglass®, in both rats and minipigs. Motivated by these findings, three MSS‐based formulations of band‐aid patch, adhesive hydrogel, and antibacterial sprays are devised for specific scenarios. Taken together, this proof‐of concept study provides a promising bioactive mineral for future clinical skin wound repair and functional appendages regeneration.

5 October 2025 in Biomaterials
Verified
Journal Article
Closed access
MGMaoqi Gong
Maoqi Gong
YZYejun Zha
Yejun Zha
SLShuai Lu
Shuai Lu
TZTongrun Zhang
Tongrun Zhang
XWXiaoqing Wang
Xiaoqing Wang
XJXieyuan Jiang
Xieyuan Jiang

14 February 2026 in Biomaterials
Verified
Journal Article
Open access
BDBingyang Dai
Bingyang Dai
LZLizhen Zheng
Lizhen Zheng
James Chung-Wai CheungJames Chung-Wai Cheung
James Chung-Wai Cheung
YLYufeng Long
Yufeng Long
JLJun Liu
Jun Liu
CDCheng Dong
Cheng Dong
Macrophages, as central orchestrators of tissue homeostasis, exhibit remarkable developmental and functional plasticity across diverse physiological and pathological contexts. Mechanistically, microenvironmental cues govern phenotypic switching, while dysregulated crosstalk with stromal cells drives fibrosis and chronic inflammation. Emerging therapeutic strategies targeting macrophages demonstrate potential in restoring tissue homeostasis. However, challenges persist in achieving spatiotemporal precision and balancing pro-repair versus pro-fibrotic outcomes. This review synthesizes current understanding of macrophage biology, encompassing their developmental origins, phenotypic heterogeneity in tissue-specific niches, and multifaceted roles in extracellular matrix (ECM) remodeling, immune surveillance, and organ homeostasis. A comprehensive view of the macrophage regulatory landscape highlights that precise spatiotemporal regulation serves as the cornerstone for macrophages to restore tissue homeostasis. Multiple innovative strategies, including macrophage-based drug delivery systems, cellular and genetic engineering of macrophages, and synergistic macrophage treatment modalities, are expanding the technical frontiers for disease diagnosis and therapeutic intervention. Future directions emphasize integrating multi-omics profiling, synthetic biology, and AI-aided biomaterials to develop 'smart' therapeutics that dynamically steer macrophage functionality. Such synergy will unravel context-dependent signaling and subset-specific interactions, which further advances our understanding of macrophage biology and its translational potential in resolving refractory diseases, and bridges mechanistic insights into transformative clinical applications.

19 May 2025 in Biomaterials
Verified
Journal Article
Open access
YAYuanming An
Yuanming An
LZLizhen Zheng
Lizhen Zheng
SZShi'An Zhang
Shi'An Zhang
HZHaozhi Zhang
Haozhi Zhang
YZYuantao Zhang
Yuantao Zhang
JXJiankun Xu
Jiankun Xu
Steroid-associated osteonecrosis (SAON) remains a challenging clinical condition as there are few effective preventive measures. This study investigates the effects of hydrogen (H2) administrated via saturated hydrogen-rich water (HRW) in mice received high dose of glucocorticoids (for inducing SAON model). Here we find that HRW treatment significantly reduces osteocyte apoptosis, improves deteriorated trabecular architecture, increases osteoblast numbers and the bone formation, while decreases osteoclast numbers and the bone resorption. Additionally, HRW-treated mice exhibit improved serum lipid profiles, including decreased levels of low-density lipoprotein (LDL), triglycerides (TG), and total cholesterol (T-CHO), as well as reduced lipid accumulation. HRW treatment also enhances blood perfusion and increases formation of type H vessels in SAON mice. We further demonstrate that HRW shifts the polarization of macrophages from M1 to M2 phenotype and suppresses inflammatory marker TNF-α. RNA sequencing data and subsequent validation reveal that HRW upregulates ACOD1 mRNA and protein levels in bone tissues. The protective effects of HRW are mimicked by supplementation with the itaconate derivative dimethyl itaconate in a dose-dependent manner, highlighting the importance of the ACOD1-itaconate pathway in the prevention of SAON by HRW. These findings indicate that HRW ameliorates SAON by modulating the ACOD1-itaconate pathway, presenting a novel avenue for the cost-effective prevention of osteonecrosis.

29 July 2025 in Interdisciplinary Materials
Verified
Journal Article
Open access
SXShunxiang Xu
Shunxiang Xu
HSHongwei Shao
Hongwei Shao
ZJZheyu Jin
Zheyu Jin
JXJiankun Xu
Jiankun Xu
FDFanyan Deng
Fanyan Deng
LQLing Qin
Ling Qin
Given the confluence of dysregulated inflammation, vasculopathy, and neuropathy, diabetic wounds pose a significant clinical challenge. Commercially available wound dressings often lack sufficient bioactivity, failing to meet clinical demands. Herein, we developed a PCL‐PLLA‐MgSiO3 (PP‐MgSi) patch with promising therapeutic effects. The PP‐MgSi composite patch was manufactured via electrospinning and characterized by controllable degradation and local release of Mg2+ and SiO32−. The patch showed favorable in vitro biocompatibility and bioactivity, notably increased angiogenesis, myelination, and neurite outgrowth. In type 2 diabetic mice, the PP‐MgSi patch exhibited MgSi dose‐dependent effects on enhancing diabetic wound healing by modulating the expression of TNF‐α, iNOS, and CD206 to balance inflammation, while boosting CD31 and β3‐tubulin levels to promote neurovascularization. With the significant suppression of pro‐inflammatory‐related TNF and IL‐17 pathways, while activating the peripheral nerve‐associated axon guidance pathway, blood vessel‐associated HIF‐1α and VEGF pathways, the PP‐MgSi patch ultimately achieved accelerated healing compared to the control group. Ultimately, the PP‐MgSi patch exhibited an accelerated repair rate, with comparable neovascularization and superior peripheral nerve regeneration capacity compared to three representative commercially available products. This proof‐of‐concept work presents a promising bioactive PP‐MgSi patch for future clinical diabetic wound management, particularly in terms of its neurovascular network recovery properties.

7 May 2026 in Biomaterials
Verified
Journal Article
Open access
YAYuanming An
Yuanming An
HZHaozhi Zhang
Haozhi Zhang
YZYuantao Zhang
Yuantao Zhang
SZShi'AN Zhang
Shi'AN Zhang
LZLizhen Zheng
Lizhen Zheng
SXShunxiang Xu
Shunxiang Xu
Long-term bisphosphonates (BPs) are widely used to treat osteoporosis, however, they are paradoxically associated with the development of atypical femoral fractures (AFFs), which often characterized by impaired healing. In this study, we induced an AFF model using zoledronate (ZOL) administration in ovariectomized (OVX) osteoporotic rats, following a unilateral femoral fracture. Here we identified that a local pro-senescent microenvironment causes persistent inflammation and impairs effective regeneration in rat AFFs. Molecular hydrogen has demonstrated anti-senescence and anti-inflammatory properties, yet its effects on AFF healing remain unexplored. Therefore, we treated the AFF rats with hydrogen rich water (HRW). The outcomes were assessed by radiographs, histology, micro-CT, and biomechanical tests. The fracture microenvironment was analyzed based on the indicators of senescence, fibrosis, macrophage polarization, cytokine expression, and angiogenesis. We found that HRW significantly promoted callus bridging and resolved the non-union gap in ZOL-induced AFFs, whereas the ZOL group exhibited persistent fibrous tissue. Micro-CT and biomechanical tests confirmed that HRW did not compromise the mechanical strength of the bone mass elevated by BPs. Instead, HRW specifically attenuated the local senescent microenvironment, with a reduction in both SA-β-gal activity and the expression of p16, p21 within the fracture gap. This was accompanied by clearance of pathological fibroblasts, a shift from pro-inflammatory M1 to anti-inflammatory M2 macrophages, a rebalanced cytokine profile, and restored formation of osteogenesis-coupled type-H vessels. Our findings confirm that molecular hydrogen facilitates AFFs healing by locally reversing the senescent microenvironment, rather than boosting systemic bone formation. This creates a favorable niche for callus bridging, representing a novel therapeutic strategy for fracture delayed union or non-union.